Ekso Bionics Implements Reverse Stock Split Strategy
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) has taken a significant step towards enhancing its market performance by announcing a reverse stock split. With an effective date set, the company aims to improve its standing on the Nasdaq Capital Market by implementing a 1-for-15 split. This decision, effective shortly, is pivotal in the company's strategy to align its stock price with regulatory requirements.
Understanding the Reverse Stock Split
The reverse stock split will mean that for every 15 shares owned, shareholders will now hold one share. This change reduces the total outstanding shares significantly, dropping from around 35 million to approximately 2.3 million shares. Importantly, this will not affect the shareholders’ total equity value. Instead, it is designed to increase the per share trading price, which is essential for maintaining compliance with Nasdaq's minimum bid price requirement.
Compliance with Nasdaq Requirements
One of the driving factors behind the reverse stock split is the necessity for Ekso Bionics to maintain compliance with listing standards on the Nasdaq Capital Market. The company is required for its stock to close at a price of at least $1.00 for ten consecutive days to meet these standards. By adjusting the number of shares in circulation, Ekso Bionics aims to achieve this price threshold and uphold its market position.
Implications for Shareholders
The decision to execute a reverse stock split has implications for all shareholders. It affects the total count of shares available, including those related to stock options and warrants. However, it is important to note that the reverse split is intended to be straight and fair, ensuring no shareholder sees a change in their overall ownership percentage of the company.
Managing Shareholder Transition
Shareholders who hold their stocks electronically via brokerage accounts will have their accounts automatically adjusted. This adjustment makes the transition smoother, negating the need for shareholders to take any active steps in response to the split. For those managing physical share certificates, they are encouraged to reach out to the company's transfer agent for information on obtaining new certificates.
Further Developments and Future Growth
Looking ahead, Ekso Bionics remains focused on its core mission of creating innovative exoskeleton solutions that enhance human capabilities. The company's commitment to developing advanced technology that improves the quality of life for individuals is evident in their ongoing projects and collaborations in the field of rehabilitation and industrial applications. Their progress in integrating advanced robotics technology is expected to be further highlighted, laying a strong foundation for future growth.
The Vision of Ekso Bionics
Ekso Bionics is dedicated to pushing the boundaries of technology with the intent to amplify human potential. By enhancing strength, endurance, and mobility through innovative robotics, the company not only improves the lives of individuals dealing with mobility challenges but also seeks to assist workers in industrial environments, ultimately contributing to enhanced productivity and safety.
Frequently Asked Questions
What is the reason for the reverse stock split by Ekso Bionics?
The reverse stock split is primarily aimed at increasing the per share trading price to comply with Nasdaq's minimum bid price requirement.
When will the reverse stock split take effect?
The reverse stock split is set to be effective from a specified date in late May, ahead of the start of trading on the Nasdaq Capital Market.
How will this affect existing shareholders?
Shareholders will see a decrease in the number of shares they own, but their total equity and ownership percentage in the company will remain unchanged.
What steps should shareholders take?
Most shareholders will not need to take any action as their brokerage firms will automatically adjust their holdings; however, those with physical certificates should contact the transfer agent.
How does this move benefit Ekso Bionics in the long run?
By improving its stock price and compliance with market requirements, Ekso Bionics aims to enhance its credibility and attract potential investors, fostering future growth opportunities.
